Kleine-Levin syndrome (KLS) is a rare neurological disorder characterized by episodes of severe hypersomnia, apathy, cognitive impairment, derealization and behavioral disturbances. Between episodes, patients have normal sleep, mood and behavior. Apathy is a prominent clinical feature of KLS but its pathophysiology is not known. Here we used mean apparent propagator to investigate white matter changes in KLS and correlated diffusion changes with apathy scores. Results showed that the corpus callosum was involved in KLS during episodes and mean RTAP measures in the corpus callosum correlated with apathy scores. Results were in accordance with known motivation-based circuits involving the orbitomedial frontal cortex.
We prospectively included 20 KLS-AS (mean age: 22.2 ± 8.9 years, 9 males) and 20 HV age and sex- matched one by one. Twelve of these 20 patients were also scanned during episodes (KLS-S). Apathy was assessed using the Starkstein Apathy score [6]. Diffusion-weighted images were acquired using a Siemens Verio 3T with a 12-channel head coil (GRAPPA=2; TR/TE=7.7s/92ms; voxel size: 2.5mm isotropic; 64, 32 and 8 gradient directions for b-values of 1800, 700, and 300 s/mm² respectively) and 8 images without diffusion weighting were also acquired.
We preprocessed the images using FSL (fsl.fmrib.ox.ac.uk/fsl/fslwiki/) and included correction for susceptibility (topup) and for eddy current distortions (eddycor) and creation of a binary mask of the brain (bet). Then, we generated RTAP maps of all subjects [7]. Voxelwise statistical analyses were carried out using TBSS, part of the FSL comparing RTAP maps of HV versus KLS-AS, HV versus KLS-S and KLS-AS versus KLS-S (paired t-test). Finally, in the TBSS-based ROI, we computed correlations between clinical scores (disease duration and apathy scores) and mean RTAP measures in this ROI and performed tractography on one healthy subject to determine its projection fibers. Results were considered significant at p<0.05, fully corrected for multiple comparisons across space.
[1] Arnulf, I., Rico, T. J., & Mignot, E. (2012). Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. The Lancet Neurology, 11(10), 918-928.
[2] Kas, A., Lavault, S., Habert, M. O., & Arnulf, I. (2014). Feeling unreal: a functional imaging study in patients with Kleine-Levin syndrome. Brain 2014 ; 137 : 2077-87.
[3] Lavault, S., Golmard, J. L., Groos, E., Brion, A., Dauvilliers, Y., Lecendreux, M., et al. Kleine-Levin syndrome in 120 patients : Differential diagnosis and long episodes. Annals of neurology 2015 ; 77 : 529-40.
[4] Levy, R. (2012). Apathy: a pathology of goal-directed behaviour. A new concept of the clinic and pathophysiology of apathy. Revue neurologique, 168(8), 585-597.
[5] Özarslan E, Koay CG, Shepherd TM, Komlosh ME, Irfanoglu MO, Pierpaoli C, Basser PJ (2013) Mean apparent propagator (MAP) MRI: A novel diffusion imaging method for mapping tissue microstructure. NImg 78:16–32. doi: 10.1016/j.neuroimage.2013.04.016
[6] Starkstein, S. E., Mayberg, H. S., Preziosi, T. J., Andrezejewski, P., Leiguarda, R., Robinson, R. G. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 1992 ; 4 : 134-9.
[7] Fick, R. H., Wassermann, D., Caruyer, E., & Deriche, R. (2016). MAPL: Tissue microstructure estimation using Laplacian-regularized MAP-MRI and its application to HCP data. NeuroImage, 134, 365-385.